Connect with us

Emerging Markets

Solar Integrated Roofing Corp (OTCMKTS: SIRC) Under Accumulation as Co Reports Record 2021 Financial Results, Its Up Listing Plan & Strategic Shift Towards EV Charging

Published

on

Solar Integrated Roofing Corp (OTCMKTS: SIRC) has been seeing some movement to the upside on a massive surge of volume after the Company reported revenue in the fiscal year ended December 31, 2021 increased 388% to $84.2 million. This follows record Q results of $48,162,928 in revenues for the 3 months ended, September 30, 2021 up from just $4,525,906 for the same period in 2020. SIRC has serious runner in its blood making a historic rise from under a penny to $3 per share in February 2021. We first reported on SIRC on September 18, 2020 when the stock was $0.066 per share as it was starting to take off. Currently the stock is still trading towards the bottom of its range but is getting noticed and volume is increasing. Management is working hard behind the scenes pn its strategic up listing strategy – first to the OTCQB and then to the NASDAQ – helping to improve liquidity and broaden SIRC shareholder base through an enhanced profile within the investment community.  

SIRC recently announced a strategic shift towards prioritizing its over $30 million electric vehicle (EV) charging project pipeline and $20.2 million EV charging project backlog given the immense near-term revenue opportunity, better aligning with the Company’s planned corporate name change to ‘SolarEV’. In conjunction with the strategy shift and to bolster its national EV charging business line, Solar Integrated Roofing has signed an LOI for an acquisition of three complementary Los Angeles-based EV charging installers with over $100 million of contracts in their sales pipeline. The Company has ambitious plans; ceo David Massey sees EV charging is the next massive opportunity in the market, and this calculated alignment of SIRC’s near-term focus will help to position the Company as a clear national player in the space. The expanding EV charging market is being driven by the rapid the adoption of electric vehicles nationwide – for example, the U.S. Energy Information Administration predicts there will be 7.5 million EVs on American roads by 2025. 

Solar Integrated Roofing Corp (OTCMKTS: SIRC) is an integrated, single-source solar power, roofing systems installation and EV charging company specializing in commercial and residential properties throughout the United States. The Company serves communities by delivering the best experience through constant innovation & legacy-focused leadership. The Company’s broad array of solutions include sales and installation of solar energy systems, battery backup and electric vehicle (EV) charging stations to roofing, HVAC and related electrical contracting work.  

SIRC has seen massive growth by rapidly acquiring other Company’s. We wrote about this in our article on SIRC on January 14, 2022 stating: The Company has been experiencing serious growth through acquisition; During the year ended February 29, 2020, Solar Integrated acquired Narrate, LLC, McKay Roofing Company Inc., Milholland Electric, and Montross Companies, Inc. in a series of cash and stock transactions. Solar Integrated has been focused on up-listing its shares to the QX exchange this year. To this end the Company has been working with OTC Markets and retained a new accounting firm with vast public company experience. The Company also named Angela Smoley, CPA as CFO of SIRC. Ms. Smoley has a background in mergers and acquisitions, auditing, corporate finance, and accounting management. Currently SIRC is listed is “pink current” on OtcMarkets.com. 

To Find out the inside Scoop on SIRC Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

SIRC

On April 5, SIRC announced that its audited financial results for the fiscal year ended December 31, 2021 are now available for download on the Company’s Disclosure page of the OTC Markets website. Revenue in the fiscal year ended December 31, 2021 increased 388% to $84.2 million, as compared to revenue of $17.3 million in 2020. The increase was driven by the Company’s continued acquisitions, as well as continued organic growth across the SIRC family of companies. Gross profit increased 807% to $40.4 million, or 48% of total revenues, in 2021, as compared to $4.5 million, or 26% of total revenues, in 2020. Net income in 2021 was $19.9 million, or $0.05 per basic and diluted common share, as compared to a net loss of $7.7 million, or $(0.05) per basic and diluted common share, in 2020. Cash and cash equivalents totaled $1.1 million as of December 31, 2021, as compared to $0.7 million at December 31, 2020.  

The Company has also made some big moves recently including securing tier-1 national solar and EV charging projects, including a $45 million co-development agreement for 17 Georgia high school solar projects and a lease agreement to build and operate a $36 million micro-grid project for a 20,000 acre farm near Kingman, Arizona announced just in October. 

CEO David Massey had this to say: “As promised, the release of our 2021 audited financial statements marks a breakthrough capital markets achievement for our company, the first step as we continue our planned transition to a fully reporting company listed on a national exchange. In addition, our shift to a more standard fiscal year ending December 31st will better align us with public company best practices and investor expectations – positioning us for future success. In addition, the fundamentals of our operations are strong as we saw both immense revenue growth and greatly enhanced margins across the board – enabling us to achieve initial profitability. We are now realizing economies of scale on the supplier side, ensuring both health margins and relative surety of product supply relative to our peers – driving the potential for enhanced net profit margins in the near-term. We also see significant promise in the SolarEV Financial Services ecosystem we have created, enabling a new financial model whereby we can finance our own projects as desired using non-dilutive debt financing. This allows us to capture substantial revenue from lucrative, hand-picked projects – while other projects we don’t finance can still be handed off to our third-party project financing partners. Our near-term focus from a capital markets perspective is now on executing upon our strategic uplisting strategy – first to the OTCQB and then to the NASDAQ – helping to improve liquidity and broaden our shareholder base through an enhanced profile within the investment community. As we move through 2023 and accomplish these exciting milestones, we are incredibly well positioned to create sustainable, long-term value for my fellow shareholders. I look forward to sustaining our robust pace of operational execution in the months ahead.”  

Microcapdaily first reported on SIRC on September 18, 2020 when the stock was $0.066 per share as the stock was beginning its spectacular rise from pennies to $3 per share. We reported at the time: “Solar Integrated Roofing Corp (OTCMKTS: SIRC) has been running higher in recent weeks quickly attracting legions of new shareholders that join a well-established shareholder base that continue to accumulate at current levels. SIRC has a long history of big moves running over $0.20 per share in August of 2019. There is plenty to get excited about on SIRC which is focused on becoming the leader in solar and roofing installation. The Company has seen rapid growth through acquisition and reported a8dited financials in February showing Solar Integration did $9,122,685 in revenues for the fiscal year ended February 23, 2020 up from $4,975,907 in 2018. Solar Integrated just retired 20 million shares of common stock, valued at over 1 million USD bringing its total OS to 138,674,132 as of September 17. 

https://twitter.com/yeg_trades/status/1511260109845897222

We have a Monster Pick Coming. Subscribe Right Now!

Currently trading at a $168,428,257 million market valuation SIRC has 481,223,590 million shares outstanding. While the Company does hold some assets its biggest by far is $41 million in account receivables and under $2 million in the treasury. They also have $60 million in current liabilities. But SIRC is an exciting story in small caps, in 2020 it should us it has serious runner in its blood skyrocketing from pennies to $3 per share, a run we reported on early when the stock was just $0.066 on September 18 2020. Since than SIRC has made numerous acquisitions and reported record annual revenues of $84 million in 2021. The Company’s focus from a capital markets perspective is now on executing upon its strategic up-listing strategy – first to the OTCQB and then to the NASDAQ – helping to improve liquidity and broaden the Company’s shareholder base through an enhanced profile within the investment community. SIRC has real potential at current levels, and a huge gap to fill from recent $3 per share highs. We will be updating on SIRC when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with SIRC.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in SIRC either long or short and we have not been compensated for this article.

Emerging Markets

Aclarion Inc (NASDAQ: ACON): A Breakthrough Partnership

Published

on

Aclarion, Inc. (NASDAQ: ACON) shares rocketed 157% Tuesday morning after their commercialization agreement with the London Clinic.

Aclarion, Inc. (NASDAQ: ACON) shares rocketed 157% Tuesday morning after their commercialization agreement with the London Clinic. The London Clinic is UK’s most renowned independent, private hospital, established 1932 with their Spine Clinic being the first specialist spinal unit based in England back in 1997.

“With a focus on providing the very best healthcare outcomes, The London Clinic is an ideal customer for Aclarion as the company works to deliver the Nociscan solution to physicians and patients around the world,” said John Sutcliffe MD, Neurosurgeon and Founder of London Spine Clinic. “The engagement with Aclarion will allow London Spine Clinic to continue offering the high-quality care our patients have come to expect. Patients need a careful assessment, diagnosis, and understanding of the different treatment options. Aclarion’s innovative Nociscan solution will enable us to objectively assess biomarkers associated with low back pain and enhance the precision of each diagnosis.”

More on Nociscan Technology

Aclarion, Inc.’s Nociscan Technology is an innovative medical solution that aims to revolutionize the diagnosis of disc-related conditions. They leverage biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain.

What’s exciting is its advantages over the current standard of care. It offers a non-invasive approach, ensuring patient comfort and safety. Given it’s non-invasive, that also means 0 pain with 0 radiation (typically associated with traditional discography). The best part is it can seamlessly integrate into standard lumbar MRI protocols, making it a convenient and efficient option for healthcare providers. 

To Discover the Inside Scoop on ACON, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

The procedure takes approximately 25-45 minutes, thoroughly evaluating spinal discs without compromising accuracy. Additionally, Nociscan technology offers significant cost savings, with a list price of $1,450, making it an affordable alternative to traditional discograms. Overall, Aclarion, Inc.’s technological advances represent a significant push forward in disc-related diagnostic techniques, prioritizing patient well-being, convenience, and affordability.

https://twitter.com/TigerLineTrades/status/1663527784143093762?s=20

Nociscan Study

They also recently completed a study that spanned two years and involved 78 patients at a single site. The success rate soared to an impressive 85% for patients whose treatment strategy aligned with the disks identified by Nociscan. This represented a remarkable 22% improvement over patients whose treatment strategy did not consider the insights provided by Nociscan.

Aclarion expressed confidence that the results of the trial demonstrate the potential of Nociscan to assist physicians in successfully treating DLBP. Dr. Matthew Gornet, orthopedic surgeon and lead author of the study, enthusiastically endorsed Nociscan, stating, “The two-year surgical outcomes of the clinical trial provide unequivocal evidence of its effectiveness, particularly with regards to the primary endpoint, the Oswestry Disability Index (ODI). I firmly believe that Nociscan has the potential to revolutionize the standard of care and accurately aid all physicians treating chronic low back pain.”

It is worth noting that although Nociscan was performed on all patients in the study, it was not part of the surgical decision-making process, as highlighted by the company.

Conclusion

The commercial agreement between Aclarion, Inc. and the prestigious London Clinic signifies a significant milestone for both parties, carrying the potential for global recognition, revenue growth, and scalability. By integrating Aclarion’s innovative Nociscan Technology, the London Clinic demonstrates its commitment to delivering cutting-edge healthcare to optimize patient well-being and enhance clinical outcomes. Furthermore, the partnership’s success holds the potential for scaling Nociscan Technology to other institutions and markets, propelling Aclarion, Inc. to become a global leader in non-invasive medical technologies while driving substantial revenue growth.

We will update you on ACON when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by PIRO from Pixabay

Continue Reading

Emerging Markets

Aemetis Inc. (NASDAQ: AMTX) Pioneers Renewable Fuel Market with EPA Approval

Published

on

Aemetis (NASDAQ: AMTX) shares surged 105% this week. The renewable natural gas and renewable fuels company received approval from the EPA.

Aemetis, Inc. (NASDAQ: AMTX) shares surged 105% this week. The renewable natural gas and renewable fuels company received approval from the U.S. EPA to generate renewable identification numbers (RINs) under the federal Renewable Fuel Standard. They have six dairy biogas digesters up and running, with a seventh one scheduled to start operating in June 2023.

Aemetis plans to generate multiple sources of revenue from its renewable natural gas. They will sell the gas to replace petroleum diesel in transportation, sell California Low Carbon Fuel Standard credits to fuel blenders who need to meet carbon reduction requirements in California, sell the RINs generated under the federal Renewable Fuel Standard, and benefit from production tax credits starting in 2025 under the Inflation Reduction Act.

They have completed constructing and operating six dairy digesters, a biogas pipeline spanning over 40 miles, a central facility to upgrade biogas to renewable natural gas, and a utility pipeline interconnection unit. The renewable natural gas is injected into the utility gas system and stored underground until Aemetis Biogas obtains carbon intensity (CI) pathway approvals from the California Air Resources Board (CARB) to sell credits under the California Low Carbon Fuel Standard.

They have already completed 90 days of renewable natural gas production and data collection required for the CARB approval process. While the final pathway is under review by CARB, Aemetis can use a temporary CI pathway with a value of -150, allowing them to start generating revenue in the third quarter of 2023.

To Discover the Inside Scoop on AMTX, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Andy Foster, the president of Aemetis Biogas Inc., expressed excitement about the approval of Aemetis Biogas for generating D3 RINs, as it marks a significant milestone towards generating full product revenue. He emphasized that the company’s investments since 2019 have directly reduced greenhouse gas pollution, improved air quality in Central Valley communities, and created jobs. Aemetis is committed to expanding their network of dairy digesters and producing more carbon-negative renewable natural gas to replace petroleum diesel.

The dairy digesters, pipeline project, and biogas-to-RNG facility funding includes grants from the California Department of Food and Agriculture and the California Energy Commission. Aemetis also closed a $25 million long-term financing deal with Greater Commercial Lending last fall, supported by a loan guarantee from the USDA. This project financing has a low fixed interest rate for the first five years and spans over 20 years.

Aemetis has plans to file applications for an additional $100 million of loans from the USDA’s REAP loan program. These funds will support the engineering, permitting, and construction of 31 more dairies. Each loan application will be limited to a maximum of $25 million and carry a 20-year repayment term.

https://twitter.com/Theweedfarmer/status/1658946668052504576?s=20

Where could Aemetis, Inc. (NASDAQ: AMTX) be in 5 years?

The company has an ambitious Five Year Plan to generate substantial revenue and reduce air and carbon pollution. The plan projects $2.0 billion in revenues, $496 million in net income, and $682 million in adjusted EBITDA by 2027, with strong compound annual growth rates. Aemetis aims to expand its operations by producing Renewable Natural Gas (RNG), Sustainable Aviation Fuel (SAF), Renewable Diesel fuel (RD), and other low-carbon products. The plan emphasizes the positive financial impact of the Inflation Reduction Act.

The plan highlights the financial benefits of the Inflation Reduction Act, which enables the transfer of tax credits and incentives related to production, projected to improve net income by $341 million in 2027.

The plan also focuses on revenue growth in all product lines, including expanding the dairy RNG business, constructing a renewable jet/diesel plant, implementing carbon sequestration, and improving energy efficiencies. 

The company has already achieved significant milestones, such as completing biogas pipeline construction, upgrading facilities for biogas-to-RNG production, and progressing in carbon sequestration and renewable jet/diesel plant development. The company has also secured a biodiesel purchase agreement in India and made strides in constructing a solar microgrid and implementing energy-efficient measures.

We will update you on AMTX when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Leopold Böttcher from Pixabay

Continue Reading

Emerging Markets

GSI Technology, Inc. (NASDAQ: GSIT): Pure AI Play Transforming Semiconductor Memory Solutions for Efficient AI Processing

Published

on

GSI Technology, Inc. (NASDAQ: GSIT) has witnessed a significant surge in its stock price, from $1.62 to $3.84, at the time of writing on Friday, May 12.

GSI Technology, Inc. (NASDAQ: GSIT) has witnessed a significant surge in its stock price, from $1.62 to $3.84, at the time of writing on Friday, May 12. This represents an impressive 137% increase; the volume has been off the hook. If you look at their historical chart, $GSIT had meager volume, sometimes as low as 300 shares traded in a day. If you do the math, that’s less than $500 worth of shares traded in a day – safe to say it was virtually illiquid.

So what happened, and what drove the stock to trade 50M shares with filings or news releases?

After an in-depth examination, GSI Technology, Inc. appears to have experienced a notable turning point in its market trajectory. The catalyst for this transformation was the company’s prominent feature on Fox News, triggering an exponential dissemination of information across various platforms. It is worth highlighting an intriguing phenomenon that tends to transpire in such circumstances: purchasing shares often induces a ripple effect, encouraging further buying activity.

With Fox News bringing the company into the spotlight and stimulating investor interest, a domino effect occurred among astute day traders who eagerly seized the opportunity to partake in this promising venture. Consequently, the trading volume for GSI Technology, Inc. skyrocketed to unprecedented levels, surpassing all previously recorded thresholds.

This surge in volume stands as a testament to the immense enthusiasm that enveloped the market as traders recognized the tremendous potential inherent in $GSIT. This collective enthusiasm resulted in an extraordinary demonstration of market engagement, reflecting a widespread acknowledgment of the company’s significance and the opportunities it presents.

https://twitter.com/SamanthaLaDuc/status/1657033207412293634?s=20

This development showcases the power of influential media coverage and underscores the intriguing dynamics that can arise when investor sentiment aligns with a compelling market narrative.

To Discover the Inside Scoop on GSIT, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Founded in 1995, GSI Technology Inc. has established itself as a prominent provider of semiconductor memory solutions. The company is focused on introducing new products that capitalize on its core strengths, which include radiation-hardened memory products for extreme environments and Gemini, an advanced processing unit (APU) designed to enhance performance in various artificial intelligence (AI) applications. Headquartered in Sunnyvale, California, GSI Technology operates sales offices in the Americas, Europe, and Asia.

GSI Technology is on the verge of reporting its earnings next week, and the company operates in the storage business, which supports the development of highly efficient AI chips. Traditionally, computing involves separate chips for storage and computation, necessitating frequent data exchange. This process incurs significant power consumption and presents scalability challenges.

To address these limitations, GSI Technology has developed a groundbreaking solution called In-memory processing. This innovation substantially reduces computation time from minutes to seconds, milliseconds, or even microseconds. Notably, it also significantly diminishes power consumption and overall cost of ownership. The key to this improvement lies in the massive parallel data processing offered by GSI’s technology, featuring two million-bit processors per chip compared to thousands found in standard graphic processing units (GPUs). Consequently, the system becomes more scalable, enabling efficient and accelerated AI processing.

By streamlining the computing process and integrating storage and computation on a single chip, GSI Technology aims to revolutionize AI processing. This approach offers notable benefits regarding power efficiency, computational speed, and scalability, making it an attractive solution for a wide range of AI applications.

In conclusion, GSI Technology, Inc. is poised to deliver innovative semiconductor memory solutions emphasizing AI chip development. The company aims to reduce computation time, power consumption, and total ownership cost through its In-memory processing technology while significantly improving scalability. With its upcoming earnings report, investors and industry observers will closely watch the company’s progress in the storage business and AI chip development.

We will update you on GSIT when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening with GSIT.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Gerd Altmann from Pixabay

Continue Reading

Trending

© All rights reserved.

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.